Home » US FDA, PAHO Agreement Could Enhance Regulatory Harmonization
US FDA, PAHO Agreement Could Enhance Regulatory Harmonization
October 14, 2010
An agreement between the U.S. Food and Drug Administration (FDA) and the Pan American Health Organization (PAHO) could enhance harmonization among regulatory authorities in the Americas, speed response times to problems in the medical supply chain and make doing business in Latin America less complicated for drug companies.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor